We are live on ! Find out more
QIPT

Quipt Home Medical

Delisted

QIPT was delisted on the 13th of March, 2026.

92 hedge funds and large institutions have $66.3M invested in Quipt Home Medical in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 14

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

5.19% more ownership

Funds ownership: 48.24%53.43% (+5.2%)

2% more funds holding

Funds holding: 9092 (+2)

0% more capital invested

Capital invested by funds: $66.1M → $66.3M (+$146K)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $33K

Holders
92
Holders Change
+2
Holders Change %
+2.22%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
12
Increased
36
Reduced
14
Closed
10
Calls
Puts
$33K
Net Calls
-$33K
Net Calls Change
-$135K
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
1
Claret Asset Management
Quebec, Canada
$13.2M -$49.3K -15,981 -0.4%
FCM
2
Forager Capital Management
Alabama
$12.2M +$5.66M +1,833,590 +78%
BlackRock
3
BlackRock
New York
$5.9M +$51K +16,529 +0.8%
RA
4
Royce & Associates
New York
$5.16M +$744K +240,980 +16%
First Manhattan
5
First Manhattan
New York
$4.67M +$617K +200,000 +14%
KCM
6
Kennedy Capital Management
Missouri
$2.79M +$12.2K +3,967 +0.4%
Russell Investments Group
7
Russell Investments Group
United Kingdom
$2.33M +$927K +300,288 +60%
Franklin Resources
8
Franklin Resources
California
$2.16M +$183K +59,441 +9%
State Street
9
State Street
Massachusetts
$1.81M +$19.5K +6,317 +1%
Boston Partners
10
Boston Partners
Massachusetts
$1.67M -$1.04M -337,385 -37%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.48M -$8.71K -2,822 -0.6%
Morgan Stanley
12
Morgan Stanley
New York
$1.01M +$511K +165,478 +91%
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$828K +$876K +283,705 New
Northern Trust
14
Northern Trust
Illinois
$731K +$14.7K +4,771 +2%
Vanguard Group
15
Vanguard Group
Pennsylvania
$706K +$111K +36,070 +18%
Renaissance Technologies
16
Renaissance Technologies
New York
$632K +$131K +42,400 +24%
PCM
17
Perritt Capital Management
Illinois
$608K +$3.91K +1,266 +0.6%
JCP
18
JB Capital Partners
New York
$584K
Truist Financial
19
Truist Financial
North Carolina
$584K +$617K +200,000 New
SO
20
STRS Ohio
Ohio
$567K +$324K +105,000 +118%
Goldman Sachs
21
Goldman Sachs
New York
$512K +$219K +70,870 +68%
Citadel Advisors
22
Citadel Advisors
Florida
$484K -$4.44K -1,438 -0.9%
N
23
Nuveen
North Carolina
$438K
KPWS
24
Kestra Private Wealth Services
Texas
$368K
Charles Schwab
25
Charles Schwab
California
$292K

QIPT Hedge Fund Activity: Q3 2024 in Review

92 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Quipt Home Medical (QIPT) for Q3 2024, worth a combined $66.3M — up 0.22% from $66.1M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new QIPT positions and 10 closed out — a net gain of 2 holders — while 36 added to existing stakes and 14 trimmed.

The largest buyer was Forager Capital Management, adding an estimated $5.66M. The largest seller was Punch & Associates Investment Management, exiting entirely with an estimated $2.78M sold.

  • 92 institutional investors held Quipt Home Medical (QIPT) as of Q3 2024, up from 90 in Q2 2024.
  • Funds reported $66.3M of Quipt Home Medical stock for Q3 2024, up 0.22% quarter-over-quarter.
  • 12 funds opened new Quipt Home Medical positions in Q3 2024 and 10 closed out, a net change of +2 holders.
  • The largest Quipt Home Medical buyer in Q3 2024 was Forager Capital Management, an estimated $5.66M added.
  • The largest Quipt Home Medical seller in Q3 2024 was Punch & Associates Investment Management, an estimated $2.78M sold.

Based on aggregated 13F filings for Q3 2024.